SUNMO: PHASE III TRIAL OF MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN VERSUS RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN IN RELAPSED/REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMA
Pavlovsky, A., Westin, J., Olszewski, A. J, Fogliatto, L., Kim, W. S., Shin, H., Leão, D., Jeon, Y., Norasetthada, L., Rego, E., Wu, H., Yin, S., Batlevi, C. L., Pham, S., Penuel, E., Jing, J., Wei, M. C., Budde, L. E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
BENDAMUSTINE, RITUXIMAB, AND POLATUZUMAB VEDOTIN FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: SINGLE‐CENTER REAL‐WORLD EXPERIENCE
Farina, K. A, Drill, E, Buie, L. W, Falchi, L, Kumar, A, Noy, A, Palomba, M L, Salles, G, Straus, D. J, Zelenetz, A. D, Buege, M. J, Batlevi, C. L
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
CHARACTERISTICS OF PATIENTS ACHIEVING COMPLETE OR PARTIAL RESPONSE (CR/PR) WITH TAZEMETOSTAT (TAZ) IN WILD‐TYPE RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Batlevi, C. L., Salles, G., Tilly, H., Chaidos, A., McKay, P., Phillips, T., Assouline, S., Campbell, P., Ribrag, V., Damaj, G. Laurent, Dickinson, M., Jurczak, W., Kaźmierczak, M., Opat, S., Radford, J. R., Schmitt, A., Rajarethinam, A., Shang, G., Morschhauser, F.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAGE FOLLICULAR LYMPHOMA
Sha, F., Okwali, M., Alperovich, A., Caron, P. C., Falchi, L., Hamilton, A., Hamlin, P. A., Horwitz, S. M., Joffe, E., Kumar, A., Matasar, M. J., Moskowitz, A. J., Noy, A., Owens, C., Palomba, L. M., Rodriguez‐Rivera, I., Straus, D., von Keudell, G., Zelenetz, A. D., Yahalom, J., Dogan, A., Schoder, H., Seshan, V. E., Salles, G., Younes, A., Batlevi, C. L.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas
Morschhauser, Franck, Salles, Gilles, Batlevi, Connie Lee, Tilly, Hervé, Chaidos, Aristeidis, Phillips, Tycel, Burke, John, Melnick, Ari
Published in Blood reviews (01.11.2022)
Published in Blood reviews (01.11.2022)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Pavlovsky, A, Westin, J, Olszewski, A J, Fogliatto, L, Kim, W S, Shin, H, Leão, D, Jeon, Y, Norasetthada, L, Rego, E, Wu, H, Yin, S, Batlevi, C L, Pham, S, Penuel, E, Jing, J, Wei, M C, Budde, L E
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
Batlevi, Connie Lee, Kasamon, Yvette, Bociek, R Gregory, Lee, Peter, Gore, Lia, Copeland, Amanda, Sorensen, Rachel, Ordentlich, Peter, Cruickshank, Scott, Kunkel, Lori, Buglio, Daniela, Hernandez-Ilizaliturri, Francisco, Younes, Anas
Published in Haematologica (Roma) (01.08.2016)
Published in Haematologica (Roma) (01.08.2016)
Get full text
Journal Article
DOSE FINDING STUDY TO ASSESS SAFETY, PK AND EFFICACY OF FIMEPINOSTAT (CUDC‐907) WITH VENETOCLAX OR RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA
Younes, A., Batlevi, C.L., Cohen, J.B., Kelly, K., Landsburg, D.J., Patel, K., Phillips, T., Smith, S., Westin, J., Ma, A.W., Grayson, D., Barta, S.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
PHASE I CLINICAL TRIAL OF CD19‐TARGETED 19‐28Z/4‐1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
Batlevi, C.L., Palomba, M.L., Park, J., Mead, E., Santomasso, B., Riviere, I., Wang, X., Senechal, B., Furman, R., Yang, J., Kane, P., Hall, M., Bernal, Y., Lund, N., Diamonte, C., Pineda, J., Halton, E., Moskowitz, C., Younes, A., Sadelain, M., Brentjens, R.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORMED MARGINAL ZONE LYMPHOMA TREATED WITH RCHOP‐LIKE REGIMENS
Rajeeve, S., Bobillo, S.V., Zelenetz, A.D., Straus, D.J., Palomba, M.L., Noy, A., Horwitz, S.M., Moskowitz, A.J., Hamlin, P.A., Matasar, M.J., Kumar, A., Batlevi, C.L., Keudell, G., Yahalom, J., Dogan, A., Drill, E., Younes, A., Joffe, E.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20ᅡ GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA
Kumar, A, Casulo, C, Advani, R, Budde, E, Barr, PM, Batlevi, CL, Chen, R, Constine, LS, Courtien, AI, Dandapani, SV, Drullinsky, P, Friedberg, JW, Hamlin, PA, Hoppe, RT, Matasar, MJ, McArthur, GN, Miller, ST, Moskowitz, AJ, Noy, A, Schoder, H, Straus, DJ, Yang, J, Younes, A, Zelenetz, AD, Yahalom, J, Moskowitz, CH
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article